PARP Inhibitors Hold Promise in Pancreas Cancer

Dr. O'Reilly reviews data on therapies in pancreatic cancer presented at ASCO 2013, including early findings suggesting that PARP inhibitors are active in this disease.

Source: Medscape Gastroenterology Podcast - June 17, 2013 Category: Gastroenterology Authors: Medscape Source Type: podcasts